Dr Reddy’s, TR-Pharm sign pact for biosimilars

By: |
Hyderabad | Published: March 12, 2016 1:00:18 AM

Dr. Reddy’s Laboratories Ltd.and Turkey-based pharma start-up TR-Pharm has formed a strategic collaboration agreement for biosimilar products.

Dr. Reddy’s Laboratories Ltd.and Turkey-based pharma start-up TR-Pharm has formed a strategic collaboration agreement for biosimilar products.

A total of three products will be registered and subsequently commercialised as a part of this agreement by TR-Pharm in Turkey.

TR-Pharm will also manufacture the drug substance and drug product upon completion of its facility investment.

TR-Pharm is a pharma start-up focused on innovation with investments into R&D and biotechnological manufacturing capability.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Next Stories
1Eco-friendly A320 Neo debuts in India, delivered to IndiGo
2Bombay HC defers Service Tax Dept plea against KFA, Vijay Mallya to Mar 28
3Harley Davidson to expand business in tier-II cities